The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Leukemia

• Publication date

  2019-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41375-018-0358-8PMID 30635626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies

  2018cited by this paper
• Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation

  2018cited by this paper
• Camptothecin and its analog SN‐38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE

  2017cited by this paper
• Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

  2017cited by this paper
• MYC Deregulation in Primary Human Cancers

  2017cited by this paper
• Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma

  2017cited by this paper
• Dual targeting of p53 and c-Myc selectively eliminates leukaemic stem cells

  2016cited by this paper
• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

  2016cited by this paper
• MYC: connecting selective transcriptional control to global RNA production

  2015cited by this paper
• Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression

  2015cited by this paper
• Single-Stranded DNA-Binding Transcriptional Regulator FUBP1 Is Essential for Fetal and Adult Hematopoietic Stem Cell Self-Renewal.

  2015cited by this paper
• Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c‐Myc and cell proliferation

  2015cited by this paper
• Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53

  2014cited by this paper
• Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue.

  2014cited by this paper
• Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity

  2014cited by this paper
• Role of far upstream element binding protein 1 in colonic epithelial disruption during dextran sulphate sodium-induced murine colitis.

  2014cited by this paper
• The Splicing Factor FUBP1 Is Required for the Efficient Splicing of Oncogene MDM2 Pre-mRNA*

  2014cited by this paper
• Overexpression of far upstream element (FUSE) binding protein (FBP)‐interacting repressor (FIR) supports growth of hepatocellular carcinoma

  2014cited by this paper
• Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.

  2014cited by this paper
• Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue.

  2014cited by this paper
• Far upstream element binding protein 1: a commander of transcription, translation and beyond

  2013cited by this paper
• Antibody orientation at bacterial surfaces has implications for both mild and severe infections

  2013cited by this paper
• Far Upstream Element-Binding Protein 1 (FUBP1) is Overexpressed in Human Gastric Cancer Tissue Compared to Non-Cancerous Tissue

  2013cited by this paper
• Differential regulation of myeloid leukemias by the bone marrow microenvironment

  2012cited by this paper
• JTV1 co‐activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress

  2011cited by this paper
• Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis

  2010cited by this paper
• Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.

  2009cited by this paper
• Overexpression of far upstream element binding proteins: A mechanism regulating proliferation and migration in liver cancer cells

  2009cited by this paper
• Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells.

  2009cited by this paper
• Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth

  2009cited by this paper
• 2‐D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis

  2008cited by this paper
• The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer

  2008cited by this paper
• Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

  2006cited by this paper
• Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma

  2006cited by this paper
• Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice

  2006cited by this paper
• Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia

  2005cited by this paper
• c-myc expression: keep the noise down!

  2005cited by this paper
• Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer

  2002cited by this paper
• Loss of FBP function arrests cellular proliferation and extinguishes c‐myc expression

  2000cited by this paper
• The P190, P210, and P230 Forms of the BCR/ABL Oncogene Induce a Similar Chronic Myeloid Leukemia–like Syndrome in Mice but Have Different Lymphoid Leukemogenic Activity

  1999cited by this paper
• A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

  1994cited by this paper
• A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.

  1990cited by this paper

• Ribosome Profiling Reveals Translational Reprogramming via mTOR Activation in Omacetaxine Resistant Multiple Myeloma.

  2025cites this paper
• Thyroid hormones contribute to JAK/STAT pathway abnormal activation, promoting T-cell lymphoma dissemination

  2025cites this paper
• Identification of lactylation-related biomarkers in osteoporosis from transcriptome and single-cell data

  2025cites this paper
• Facilitation of diabetic wound healing by far upstream element binding protein 1 through augmentation of dermal fibroblast activity

  2024cites this paper
• FUBP1 in human cancer: Characteristics, functions, and potential applications

  2024influential citation
• Far upstream element‐binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma

  2023cites this paper
• Interaction of Camptothecin Anticancer Drugs with Ribosomal Proteins L15 and L11: A Molecular Docking Study

  2023cites this paper
• FUBP3 regulates chronic myeloid leukaemia progression through PRC2 complex regulated PAK1‐ERK signalling

  2022cites this paper
• Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1)

  2022cites this paper
• Human Adipose-Derived Mesenchymal Stromal Cells Exhibit High HLA-DR Levels and Altered Cellular Characteristics under a Xeno-free and Serum-free Condition

  2021cites this paper
• BiSEK: a platform for a reliable differential expression analysis

  2021cites this paper
• Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells

  2021cites this paper
• TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer

  2021cites this paper
• The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC

  2021cites this paper
• LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC

  2021cites this paper
• Loganetin and 5‐fluorouracil synergistically inhibit the carcinogenesis of gastric cancer cells via down‐regulation of the Wnt/β‐catenin pathway

  2020cites this paper
• Multiple Functions of Fubp1 in Cell Cycle Progression and Cell Survival

  2020cites this paper
• Long non-coding RNA small nucleolar RNA host gene 6 aggravates pancreatic cancer through upregulation of far upstream element binding protein 1 by sponging microRNA-26a-5p

  2020cites this paper
• Cell Biology International

  2020cites this paper
• Irinotecan: 25 years of cancer treatment.

  2019cites this paper